Literature DB >> 20005530

Midterm outcomes of myocardial revascularization in children.

Nicola Viola1, Abdullah A Alghamdi, Osman O Al-Radi, John G Coles, Glen S Van Arsdell, Christopher A Caldarone.   

Abstract

OBJECTIVE: Pediatric coronary artery bypass grafting is uncommon. Small target vessels and appropriate conduit choice are the main technical challenges.
METHODS: Fourteen patients undergoing coronary artery bypass grafting from January 1986 to December 2008 were retrospectively reviewed.
RESULTS: Median age was 10 years (range, 3-15 years); median weight was 36 kg (range, 12-71 kg). Indications included symptoms or evidence of inducible ischemia and angiographically documented coronary stenosis. Diagnoses included Kawasaki disease (5/14), anomalous left coronary artery originating from the pulmonary artery (2/14), previous stent implant (1/14), and metabolic disease (3/14). The remaining 3 patients had coronary stenosis after other cardiac operations. Preoperatively 5 patients (45%) had no symptoms and 9 (64%) had positive stress test. Single-vessel disease was demonstrated in 2 (14%), double-vessel disease in 7 (50%), triple-vessel disease in 1 (7%), and left main coronary artery involvement in 4 (29%). With standard cardiopulmonary bypass, 18 (81%) in situ internal thoracic arteries and 4 (19%) long saphenous veins were grafted. There was 1 early reoperation for graft failure. All patients survived to hospital discharge. Follow-up angiography was performed in 5 patients (36%; median, 2 years; range, 1 day-10 years), and 1 (7%) required late balloon dilatation. Median follow-up was 3.3 years (1 month-10 years), and 12 patients had no symptoms. There was 1 late death of noncardiac cause.
CONCLUSIONS: Pediatric coronary artery bypass grafting can be performed for a wide range of indications. Midterm results are excellent. Preoperative stress testing can detect silent myocardial ischemia. 2010 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20005530     DOI: 10.1016/j.jtcvs.2009.09.005

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  7 in total

1.  Rescue of Coronary Injury with Right Internal Mammary Artery Bypass during Repair of a Complex Congenital Heart.

Authors:  Ming-Yuan Kang; Hao-Ji Wei; Chung-Chi Wang; Yen Chang
Journal:  Acta Cardiol Sin       Date:  2015-07       Impact factor: 2.672

2.  Outcomes after surgical coronary artery revascularisation in children with congenital heart disease.

Authors:  Kalpana Thammineni; Jeffrey M Vinocur; Brian Harvey; Jeremiah S Menk; Michael Scott Kelleman; Anna-Maria Korakiti; Amanda S Thomas; James H Moller; James D St Louis; Lazaros K Kochilas
Journal:  Heart       Date:  2018-02-22       Impact factor: 5.994

3.  Stent implantation of left main coronary artery stenosis in an infant: Effective long-term treatment?

Authors:  Christian Paech; Ingo Dähnert; Frank Thomas Riede
Journal:  Ann Pediatr Cardiol       Date:  2015 May-Aug

Review 4.  A new arena in cardiac surgery: Pediatric coronary artery bypass surgery.

Authors:  Soichiro Kitamura
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2018       Impact factor: 3.493

5.  Surgical myocardial revascularization outcomes in Kawasaki disease: systematic review and meta-analysis.

Authors:  Antonio Salsano; Jingda Liao; Ambra Miette; Massimo Capoccia; Giovanni Mariscalco; Francesco Santini; Antonio F Corno
Journal:  Open Med (Wars)       Date:  2021-03-09

Review 6.  Cardiac surgical procedures for the coronary sequelae of Kawasaki disease.

Authors:  Shi-Min Yuan
Journal:  Libyan J Med       Date:  2012-12-03       Impact factor: 1.657

Review 7.  Pediatric Coronary Artery Revascularization Surgery: Development and Effects on Survival, Cardiac Events and Graft Patency for Children With Kawasaki Disease Coronary Involvements.

Authors:  Soichiro Kitamura
Journal:  Iran J Pediatr       Date:  2016-01-30       Impact factor: 0.364

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.